Neurovision Limited
11945328
Healthy
No risk factors detected.
Details
Compliance
Last accounts
30/04/2025
micro entity
Next accounts due
31/01/2027
Confirmation statement
Last: 12/04/2025
Due 26/04/2026
Industry
Officers
Persons with Significant Control
Dr Arvind Chandratheva
British · United Kingdom · Age 50
C/O Sandison Easson & Co, Rex Buildings, Wilmslow, SK9 1HY
Notified 13/04/2019
Dr Sweta Kothari
British · United Kingdom · Age 49
C/O Sandison Easson & Co, Rex Buildings, Wilmslow, SK9 1HY
Notified 13/04/2019
CompanyRankvs 5015+ SIC 86220 peers69
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/04/2025
Net Worth
£67k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£61k
Working capital
Current Assets
£63k
Current Liabilities
£2k
Fixed Assets
£6k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 28.73 | -£11k |
| 2024 | 9.62 | +£9k |
| 2023 | 2.38 | +£25k |
| 2022 | 2.17 | +£16k |
| 2021 | 1.70 | -£33k |
| 2020 | 2.94 | — |
Derived from filed accounts. Not audited figures.